Detecting APC Gene Mutations in Familial Adenomatous Polyposis (FAP)

Babi Ramesh Reddy Nallamilli1, Madhuri Hegde1

1 Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia
Publication Name:  Current Protocols in Human Genetics
Unit Number:  Unit 10.8
DOI:  10.1002/cphg.29
Online Posting Date:  January, 2017
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Hereditary forms of colorectal cancer (CRC) account for up to 5% of total cases. Familial adenomatous polyposis (FAP) is an autosomal dominant condition affecting nearly 1 in 5000 people and accounts for only about 1% of all CRCs. It is characterized by the progressive development of hundreds to thousands of adenomatous colon polyps. The gene associated with FAP (APC) contains 15 coding exons. The mutation spectrum of the APC gene is broad in that 87% of causative mutations are point mutations (including other sequence variants) and around 10% to 15% are intragenic deletions and duplications. The strategy for molecular diagnostic testing for FAP involves initial full sequence analysis of APC for sequence variants followed by screening for deletion/duplications using microarray‐based comparative genomic hybridization (array CGH) or Multiplex Ligation‐dependent Probe Amplification (MLPA). Recently, next generation sequencing (NGS)‐based targeted gene analysis has become clinically available for detection of point mutations and other sequence variants. This unit discusses detailed protocols for an NGS‐based sequencing assay, PCR‐based Sanger sequencing, and array CGH. © 2017 by John Wiley & Sons, Inc.

Keywords: APC gene; NGS‐based sequencing; Sanger sequencing; array CGH

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Basic Protocol 1: Targeted Next Generation Sequencing of APC Using IDT xGen Lockdown Probes
  • Support Protocol 1: DNA Isolation from Whole Blood
  • Basic Protocol 2: Sanger Sequencing of Entire APC Coding Region to Detect Point Mutations
  • Basic Protocol 3: Microarray‐Based Comparative Genomic Hybridization to Detect Deletions and Duplications in APC Gene
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Targeted Next Generation Sequencing of APC Using IDT xGen Lockdown Probes

  Materials
  • 5 µM APC exon‐specific forward primer
  • 5 µM APC exon‐specific reverse primer
  • Genomic DNA from FAP patient
  • 10× PCR buffer with MgCl 2 (e.g., Roche)
  • 10 mM dNTPs (e.g., Roche)
  • 5 U/µl FastStart Taq DNA polymerase (e.g., Roche)
  • Nuclease‐free water
  • 2% agarose gel
  • BigDye Terminator v3.1 Cycle Sequencing Kit (e.g., Thermo Fisher Scientific) containing:
    • 5× sequencing buffer
    • BigDye Terminator v3.1 ready reaction mix
    • M13 forward or M13 reverse primer
  • Melatonin (e.g., Sigma, cat. no. M5250‐1G)
  • NanoDrop spectrophotometer
  • 96‐well PCR plate
  • Centrifuge with plate spinning adaptor
  • Thermal cycler
  • MultiScreen PCR purification plate (e.g., Millipore)
  • MultiScreen vacuum manifold (e.g., Millipore)
  • PCR plate mixer
  • 96‐well Performa DTR Version 3 purification plates (e.g., Egde BioSystems)
  • Septa for 96‐well plate
  • Vortex
  • ABI 3730 sequencer
  • APC reference file (available at NCBI Web site)
  • Mutation Surveyor software (e.g., SoftGenetics)
  • Additional reagents and equipment for agarose gel electrophoresis (Voytas, )
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
  Bapat, B., Berk, T., Mitri, A., Cohen, Z., Gallinger, S., and Stern, H. 1994. Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP). Hum. Mutat. 4:253‐256. doi: 10.1002/humu.1380040404.
  Baxevanis, A.D. 2012. Searching online mendelian inheritance in man (OMIM) for information on genetic loci involved in human disease. Curr. Protoc. Hum. Genet. 73:9.13.1‐9.13.10. doi: 10.1002/0471142905.hg0913s73.
  Benson, A.B., 3rd, Bekaii‐Saab, T., Chan, E., Chen, Y.J., Choti, M.A., Cooper, H.S., Engstrom, P.F., Enzinger, P.C., Fakih, M.G., Fenton, M.J., Fuchs, C.S., Grem, J.L., Hunt, S., Kamel, A., Leong, L.A., Lin, E., May, K.S., Mulcahy, M.F., Murphy, K., Rohren, E., Ryan, D.P., Saltz, L., Sharma, S., Shibata, D., Skibber, J.M., Small, W., Jr., Sofocleous, C.T., Venook, A.P., Willett, C.G., Gregory, K.M., and Freedman‐Cass, D.A. 2013. Metastatic colon cancer, version 3.2013: Featured updates to the NCCN Guidelines. J. Natl. Compr. Canc. Netw. 11:141‐152.
  Bodmer, W. 1999. Familial adenomatous polyposis (FAP) and its gene, APC. Cytogenet. Cell Genet. 86:99‐104. doi: 10.1159/000015360.
  Chin, E.L., da Silva, C., and Hegde, M. 2013. Assessment of clinical analytical sensitivity and specificity of next‐generation sequencing for detection of simple and complex mutations. BMC Genet 14:6. doi: 10.1186/1471‐2156‐14‐6.
  Claes, K., Dahan, K., Tejpar, S., De Paepe, A., Bonduelle, M., Abramowicz, M., Verellen, C., Franchimont, D., Van Cutsem, E., and Kartheuser, A. 2011. The genetics of familial adenomatous polyposis (FAP) and MutYH‐associated polyposis (MAP). Acta Gastroenterol. Belg. 74:421‐426.
  Cottrell, S., Bicknell, D., Kaklamanis, L., and Bodmer, W.F. 1992. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet 340:626‐630. doi: 10.1016/0140‐6736(92)92169‐G.
  De Rosa, M., Scarano, M.I., Panariello, L., Morelli, G., Riegler, G., Rossi, G.B., Tempesta, A., Romano, G., Renda, A., Pettinato, G., and Izzo, P. 2003. The mutation spectrum of the APC gene in FAP patients from southern Italy: Detection of known and four novel mutations. Hum. Mutat. 21:655‐656. doi: 10.1002/humu.9151.
  Dobbie, Z., Spycher, M., Hurliman, R., Ammann, R., Ammann, T., Roth, J., Muller, A., Muller, H., and Scott, R.J. 1994. Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene. Eur. J. Cancer. 30A:1709‐1713. doi: 10.1016/0959‐8049(94)00294‐F.
  Fodde, R. 2002. The APC gene in colorectal cancer. Eur. J. Cancer. 38:867‐871. doi: 10.1016/S0959‐8049(02)00040‐0.
  Gargis, A.S., Kalman, L., Bick, D.P., da Silva, C., Dimmock, D.P., Funke, B.H., Gowrisankar, S., Hegde, M.R., Kulkarni, S., Mason, C.E., Nagarajan, R., Voelkerding, K.V., Worthey, E.A., Aziz, N., Barnes, J., Bennett, S.F., Bisht, H., Church, D.M., Dimitrova, Z., Gargis, S.R., Hafez, N., Hambuch, T., Hyland, F.C., Luna, R.A., MacCannell, D., Mann, T., McCluskey, M.R., McDaniel, T.K., Ganova‐Raeva, L.M., Rehm, H.L., Reid, J., Campo, D.S., Resnick, R.B., Ridge, P.G., Salit, M.L., Skums, P., Wong, L.J., Zehnbauer, B.A., Zook, J.M., and Lubin, I.M. 2015. Good laboratory practice for clinical next‐generation sequencing informatics pipelines. Nat. Biotechnol. 33:689‐693. doi: 10.1038/nbt.3237.
  Goodenberger, M. and Lindor, N.M. 2011. Lynch syndrome and MYH‐associated polyposis: Review and testing strategy. J. Clin. Gastroenterol. 45:488‐500. doi: 10.1097/MCG.0b013e318206489c.
  Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., and Robertson, M. 1991. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589‐600. doi: 10.1016/0092‐8674(81)90021‐0.
  Groden, J., Gelbert, L., Thliveris, A., Nelson, L., Robertson, M., Joslyn, G., Samowitz, W., Spirio, L., Carlson, M., Burt, R., Leppert, M., and White, R. 1993. Mutational analysis of patients with adenomatous polyposis: Identical inactivating mutations in unrelated individuals. Am. J. Hum. Genet. 52:263‐272.
  Harrison, S.M., Riggs, E.R., Maglott, D.R., Lee, J.M., Azzariti, D.R., Niehaus, A., Ramos, E.M., Martin, C.L., Landrum, M.J., and Rehm, H.L. 2016. Using ClinVar as a resource to support variant interpretation. Curr. Protoc. Hum. Genet. 89:8.16.1‐8.16.23. doi: 10.1002/0471142905.hg0816s89.
  Hegde, M., Ferber, M., Mao, R., Samowitz, W., Ganguly, A., Working Group of the American College of Medical Genetics, and Genomics Laboratory Quality Assurance Committee. 2014. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH‐associated polyposis). Genet. Med. 16:101‐116. doi: 10.1038/gim.2013.166.
  Joslyn, G., Richardson, D.S., White, R., and Alber, T. 1993. Dimer formation by an N‐terminal coiled coil in the APC protein. Proc. Natl. Acad. Sci. U.S.A. 90:11109‐11113. doi: 10.1073/pnas.90.23.11109.
  Kinzler, K.W., Nilbert, M.C., Su, L.K., Vogelstein, B., Bryan, T.M., Levy, D.B., Smith, K.J., Preisinger, A.C., Hedge, P., and McKechnie, D. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661‐665. doi: 10.1126/science.1651562.
  Knudson, A.G. Jr. 1995. Hereditary cancers: From discovery to intervention. J. Natl. Cancer Inst. Monogr. 17:5‐7.
  Knudson, A.G. 1996. Hereditary cancer: Two hits revisited. J. Cancer Res. Clin. Oncol. 122:135‐140. doi: 10.1007/BF01366952.
  Leoz, M.L., Carballal, S., Moreira, L., Ocana, T., and Balaguer, F. 2015. The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl. Clin. Genet. 8:95‐107. doi: 10.2147/TACG.S51484.
  Mihalatos, M., Danielides, I., Belogianni, J., Harokopos, E., Papadopoulou, E., Kalimanis, G., Tsiava, M., Triantafillidis, J.K., Kosmidis, P.A., Fountzilas, G., Basdanis, G., Agnantis, N.J., Yannoukakos, D., and Nasioulas, G. 2003. Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients. Cancer Genet. Cytogenet. 141:65‐70. doi: 10.1016/S0165‐4608(02)00723‐9.
  Miyaki, M., Konishi, M., Kikuchi‐Yanoshita, R., Enomoto, M., Igari, T., Tanaka, K., Muraoka, M., Takahashi, H., Amada, Y., and Fukayama, M. 1994. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res. 54:3011‐3020.
  Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. 1992. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum. Mol. Genet. 1:229‐233. doi: 10.1093/hmg/1.4.229.
  Nallamilli, B.R.R., Ankala, A., and Hegde, M. 2014. Molecular diagnosis of Duchenne Muscular Dystrophy. Curr. Protoc. Hum. Genet. 83:9.25.1‐9.25.29. doi: 10.1002/0471142905.hg0925s83.
  Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., and Hedge, P. 1991. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665‐669. doi: 10.1126/science.1651563.
  Su, L.K., Kohlmann, W., Ward, P.A., and Lynch, P.M. 2002. Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15. Hum. Genet. 111:88‐95. doi: 10.1007/s00439‐002‐0758‐7.
  van der Luijt, R.B., Vasen, H.F., Tops, C.M., Breukel, C., Fodde, R., and Meera Khan, P. 1995. APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Hum. Genet. 96:705‐710. doi: 10.1007/BF00210303.
  van der Luijt, R.B., Meera Khan, P., Vasen, H.F., Breukel, C., Tops, C.M., Scott, R.J., and Fodde, R. 1996. Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum. Genet. 98:727‐734. doi: 10.1007/s004390050293.
  van der Luijt, R.B., Khan, P.M., Vasen, H.F., Tops, C.M., van Leeuwen‐Cornelisse, I.S., Wijnen, J.T., van der Klift, H.M., Plug, R.J., Griffioen, G., and Fodde, R. 1997. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum. Mutat. 9:7‐16. doi: 10.1002/(SICI)1098‐1004(1997)9:1%3c7::AID‐HUMU2%3e3.0.CO;2‐8.
  Varesco, L. 2004. Familial adenomatous polyposis: Genetics and epidemiology. Tech Coloproctol. 8(Suppl 2):s305‐s308. doi: 10.1007/s10151‐004‐0182‐1.
  Voytas, D. 2001. Agarose gel electrophoresis. Curr. Protoc. Mol. Biol. 51:2.5A.1‐2.5A.9. doi: 10.1002/0471142727.mb0205as51.
  Wei, X., Dai, Y., Yu, P., Qu, N., Lan, Z., Hong, X., Sun, Y., Yang, G., Xie, S., Shi, Q., Zhou, H., Zhu, Q., Chu, Y., Yao, F., Wang, J., He, J., Yang, Y., Liang, Y., Qi, M., Yang, L., Wang, W., Wu, H., Duan, J., Shen, C., Cui, L., and Yi, X. 2014. Targeted next‐generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: A multi‐population diagnostic study. Eur. J. Hum. Genet. 22:110‐118. doi: 10.1038/ejhg.2013.82.
  Worthey, E.A. 2013. Analysis and annotation of whole‐genome or whole‐exome sequencing–derived variants for clinical diagnosis. Curr. Protoc. Hum. Genet. 79:9.24:9.24.1–9.24.24. doi: 10.1002/0471142905.hg0924s79.
  Wu, G., Wu, W., Hegde, M., Fawkner, M., Chong, B., Love, D., Su, L.K., Lynch, P., Snow, K., and Richards, C.S. 2001. Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high‐performance liquid chromatography. Genet. Test 5:281‐290. doi: 10.1089/109065701753617408.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library